Antiphospholipid antibody syndrome

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 9, 2011, Pages 1092-1096

  Sangle, Nikhil A ^a,b   Smock, Kristi J ^a,b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; CORTICOSTEROID; HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; BLOOD; HUMAN; IMMUNOLOGY; REVIEW; THROMBOEMBOLISM; THROMBOPHILIA;

ADRENAL CORTEX HORMONES; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HEPARIN; HUMANS; LUPUS COAGULATION INHIBITOR; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 80052892944     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/2010-0325-RSR.1     Document Type: Review

References (30)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306.
2. Triplett DA. Antiphospholipid antibodies. Arch Pathol Lab Med. 2002; 126(11):1424-1429. (Pubitemid 36237295)
3. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009;7(10):1737-1740.
4. Pierangeli SS, Chen PP, Raschi E, Et A. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenetic mechanisms. Semin Thromb Hemost. 2008;34(3):236-250.
5. Rand JH, Wu XX, Quinn AS, Taatjes DJ. Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome. Lupus. 2008;17(10):922-930.
6. Jude B, Goudemand J, Dolle I, Author C. Lupus anticoagulant: a clinical and laboratory study of 100 cases. Clin Lab Haematol. 1988;10:41-51.
7. Conley CL, Hartmann RC. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest. 1952;152:621-622.
8. Moore JE, Lutz WB. The natural history of systemic erythematosus: an approach to its study through chronic biologic false-positive reactors. J Chronic Dis. 1955;1(3):297-316.
9. Feinstein DI, Rapaport SI. Acquired inhibitors of coagulation. Prog Hemost Thromb. 1972;1:75-95.
10. Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force. J Clin Pathol. 1991;44(11):885-889.
11. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost. 1995;74(4):1185-1190.
12. Greer JP, Foerester J, Rodgers GM, Glader B, eds. Wintrobe's clinical hematology. 12th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009.
13. Gastineau DA, Kazmier FJ, Nichols WL, Bowie EJ. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol. 1985; 19(3):265-275. (Pubitemid 15033408)
14. Mueh JR, Herbst KD, Rapaport SI. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med. 1980;92(2, pt 1):156-159. (Pubitemid 10141570)
15. Boggild MD, Sedhev RV, Fraser D, Heron JR. Cerebral venous sinus thrombosis and antiphospholipid antibodies. Postgrad Med J. 1995;71(838):487- 489.
16. Saidi S, Mahjoub T, Almawi WY. Lupus anticoagulants and antiphospholipid antibodies as risk factors for a first episode of ischemic stroke. J Thromb Haemost. 2009;7(7): 1075-1080.
17. Brey RL, Chapman J, Levine SR, et al. Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. Lupus. 2003;12(7):508-513. (Pubitemid 36890141)
18. Lim W. Antiphospholipid antibody syndrome. Hematology Am Soc Hematol Educ Program. 2009:233-239.
19. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003; 101(5):1827-1832. (Pubitemid 36237580)
20. Galli M. The antiphospholipid triangle. J Thromb Haemost. 2010;8(2): 234-236.
21. Stasi R, Stipa E, Masi M, et al. Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma. Thromb Haemost. 1993;70(4):568-572. (Pubitemid 23310557)
22. Prieto J, Yuste JR, Beloqui O, et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology. 1996;23(2): 199-204. (Pubitemid 26045934)
23. Bloom EJ, Abrams Dl, Rodgers G. Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA. 1986;256(4):491-493. (Pubitemid 16090581)
24. Facer CA, Agiostratidou G. High levels of anti-phospholipid antibodies in uncomplicated and severe Plasmodium falciparum and in P. vivax malaria. Clin Exp Immunol. 1994;95(2):304-309. (Pubitemid 24207144)
25. Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. J Rheumatol. 1998;25(4):667-674. (Pubitemid 28212373)
26. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine (Baltimore). 1998;77(3):195-207. (Pubitemid 28290020)
27. Wong RC, Favaloro EJ. A consensus approach to the formulation of guidelines for laboratory testing and reporting of antiphospholipid antibody assays. Semin Thromb Hemost. 2008;34(4):361-372.
28. Ordi-Ros J, Perez-Peman P, Monasterio J. Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies). Haemostasis. 1994;24(3): 165-174. (Pubitemid 24244288)
29. Pernod G, Arvieux J, Carpentier PH, Mossuz P, Bosson JL, Polack B. Successful treatment of lupus anticoagulant-hypoprothrombinemia syndrome using intravenous immunoglobulins. Thromb Haemost. 1997;78(2):969-970. (Pubitemid 27365604)
30. Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol. 2003;101(6): 1333-1344. (Pubitemid 36694363)